Clinical Trial Update: Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating tezepelumab with methacholine-induced airway hyperresponsiveness in adults with mild allergic asthma; status and results are not pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: McMaster University | Conditions: Asthma, Allergic | Phase 2 | Status: UNKNOWN